Credible sets and evidence of colocalization. by Daniela Fusco (10027975)

Subjects:

Genetic correlations between sMRI traits and BMI. by Daniela Fusco (10027975)

Subjects:

Levels of pro- and anti-inflammatory cytokines in BALF. by Guoqing Meng (4669774)

Subjects:

Perioperative IL-6 and sIL-6r dynamics for rs2228145. by Kyle D. Anderson (2296873)

Perioperative IL-6 and sIL-6r dynamics for rs4537545. by Kyle D. Anderson (2296873)

Perioperative IL-6 and sIL-6r dynamics according to rs2069845 allele status. by Kyle D. Anderson (2296873)

Bar chart of state-wise annual temperature shift. by MD. Nahid Hassan Nishan (22264861)

“…Across most states, a slight decrease in age at menarche was observed, with the exception of Maharashtra, which showed an increase. …”

Demographic characteristics of the participants. by MD. Nahid Hassan Nishan (22264861)

“…Across most states, a slight decrease in age at menarche was observed, with the exception of Maharashtra, which showed an increase. …”

Increases in temperature for the two drill systems at different positions using different drilling procedures. The data in bold indicate the position where the highest mean tempera... by Marsel Ganeyev (21453399)

Subjects:

Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. by Masashi Okawa (8951294)

Subjects:

The characteristics and clinical features of 12 patients. by Masashi Okawa (8951294)

Subjects:

Effect of adding rhVEGF-A (-121 or -165) on the concentrations of VEGF-A121 and VEGF-A165 in plasma samples. by Masashi Okawa (8951294)

Subjects:

Effect of the VEGF-A–bevacizumab complex removal using immunoprecipitation on the concentrations of VEGF-A121, VEGF-A165, and VEGF-A. by Masashi Okawa (8951294)

Subjects:

Equation of the equilibrium dissociation constant of the antigen-antibody reaction. by Masashi Okawa (8951294)

Subjects:

The original data for the figures. by Masashi Okawa (8951294)

Subjects:

Blood concentrations of VEGF-A121, VEGF-A165, and VEGF-A pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

VEGF-A121, VEGF-A165, and VEGF-A contents per unit platelets. by Masashi Okawa (8951294)

Subjects:

Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

Hypothetical mechanism by which plasma VEGF-A121 concentration is elevated post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

Epigenetic fine mapping and motif analysis for the TUFM locus. by Daniela Fusco (10027975)

Subjects: